Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - clindamycin phosphate, quantity: 1.188 % w/w - gel - excipient ingredients: propylene glycol; sodium hydroxide; purified water; hyetellose; ethanol; zinc acetate - zindaclin is indicated for the treatment of acne vulgaris, particularly forms in which comedones, papules and pustules predominate.

Australia - English - Department of Health (Therapeutic Goods Administration)

actavis pty ltd - clindamycin phosphate -

Israel - English - Ministry of Health

taro international ltd, israel - clindamycin phosphate - gel - clindamycin phosphate 1 %w/w - clindamycin - clindamycin - zindaclin is indicated for the treatment of acne vulgaris.

Ireland - English - HPRA (Health Products Regulatory Authority)

kci europe holding b.v. - clindamycin phosphate - gel - 1 percent weight/weight - antiinfectives for treatment of acne; clindamycin

Ireland - English - HPRA (Health Products Regulatory Authority)

canute pharma (ireland) limited - clindamycin phosphate - gel - 1 percent weight/weight - antiinfectives for treatment of acne; clindamycin

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

orient europharma (m) sdn bhd - clindamycin phosphate -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

canute pharma ltd - clindamycin phosphate - cutaneous gel - 10mg/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lexon (uk) ltd - clindamycin phosphate - cutaneous gel - 10mg/1gram

Ireland - English - HPRA (Health Products Regulatory Authority)

crawford healthcare limited - clindamycin phosphate - gel - 1 percent weight/weight - antiinfectives for treatment of acne; clindamycin